The presence of thyroglobulin antibodies, the need for levothyroxine medication, and a higher likelihood of thyroid dysfunction were all substantially linked with moderate rather than mild manifestations of COVID-19 (OR 5.33; 95% CI: 1.70–16.69, P=0.002). This evidence concerns the gene TG and COVID-19.